The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Stem cell, Granulocyte Colony Stimulating Factor and or Dihexa to promote limb function recovery in a rat sciatic nerve damage repair model: Experimental animal studies ScienceDirect The mechanism of action of Dihexa_Chemicalbook Dihexa Research Grade Neurotrophic Molecule 20 mg PRG Dihexa Peptide Therapy Cognitive & Brain Function TX DIHEXA